These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 21715129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Redox active copper chelate overcomes multidrug resistance in T-lymphoblastic leukemia cell by triggering apoptosis.
    Ganguly A, Basu S, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Chaudhuri SK.
    Mol Biosyst; 2011 May; 7(5):1701-12. PubMed ID: 21409205
    [Abstract] [Full Text] [Related]

  • 3. An in vitro and in vivo study of a novel zinc complex, zinc N-(2-hydroxyacetophenone)glycinate to overcome multidrug resistance in cancer.
    Ghosh RD, Das S, Ganguly A, Banerjee K, Chakraborty P, Sarkar A, Chatterjee M, Nanda A, Pradhan K, Choudhuri SK.
    Dalton Trans; 2011 Nov 07; 40(41):10873-84. PubMed ID: 21717020
    [Abstract] [Full Text] [Related]

  • 4. A novel manganese complex, Mn-(II) N-(2-hydroxy acetophenone) glycinate overcomes multidrug-resistance in cancer.
    Ghosh RD, Banerjee K, Das S, Ganguly A, Chakraborty P, Sarkar A, Chatterjee M, Choudhuri SK.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):737-47. PubMed ID: 23665413
    [Abstract] [Full Text] [Related]

  • 5. Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer.
    Basu S, Ganguly A, Chakraborty P, Sen R, Banerjee K, Chatterjee M, Efferth T, Choudhuri SK.
    Biochimie; 2012 Jan 16; 94(1):166-83. PubMed ID: 22037022
    [Abstract] [Full Text] [Related]

  • 6. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S, Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S, Choudhuri SK.
    Clin Cancer Res; 2006 Jul 15; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [Abstract] [Full Text] [Related]

  • 7. A newly synthesized nickel chelate can selectively target and overcome multidrug resistance in cancer through redox imbalance both in vivo and in vitro.
    Banerjee K, Biswas MK, Choudhuri SK.
    J Biol Inorg Chem; 2017 Dec 15; 22(8):1223-1249. PubMed ID: 29063196
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M.
    PLoS One; 2007 Aug 01; 2(8):e693. PubMed ID: 17668070
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Majumder S, Dutta P, Mookerjee A, Choudhuri SK.
    Chem Biol Interact; 2006 Feb 01; 159(2):90-103. PubMed ID: 16289015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Overcoming of multidrug resistance by a newly synthesized quinoline compound, MS-209].
    Naito M, Nakanishi O, Tsuruo T.
    Nihon Rinsho; 1997 May 01; 55(5):1122-7. PubMed ID: 9155163
    [Abstract] [Full Text] [Related]

  • 16. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
    Abu Ajaj K, Graeser R, Kratz F.
    Breast Cancer Res Treat; 2012 Jul 01; 134(1):117-29. PubMed ID: 22228402
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
    Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H, Date H.
    Cancer Gene Ther; 2009 Jan 01; 16(1):65-72. PubMed ID: 18654608
    [Abstract] [Full Text] [Related]

  • 19. Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
    Ganguly A, Chakraborty P, Banerjee K, Chatterjee S, Basu S, Sarkar A, Chatterjee M, Choudhuri SK.
    Biometals; 2012 Feb 01; 25(1):149-63. PubMed ID: 21915630
    [Abstract] [Full Text] [Related]

  • 20. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC, Guan Y, Soenen DR, Danishefsky SJ, Boger DL.
    Cancer Chemother Pharmacol; 2005 Oct 01; 56(4):379-90. PubMed ID: 15875185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.